Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 11 | 2024 | 669 | 2.210 |
Why?
|
| Fontan Procedure | 3 | 2023 | 191 | 1.170 |
Why?
|
| Pulmonary Veins | 2 | 2024 | 167 | 0.940 |
Why?
|
| Heart Defects, Congenital | 8 | 2024 | 1887 | 0.910 |
Why?
|
| Stenosis, Pulmonary Vein | 1 | 2024 | 24 | 0.860 |
Why?
|
| Angioplasty, Balloon | 1 | 2024 | 162 | 0.790 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2023 | 148 | 0.730 |
Why?
|
| India | 13 | 2025 | 239 | 0.710 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 225 | 0.700 |
Why?
|
| Stents | 3 | 2024 | 881 | 0.620 |
Why?
|
| Cardiovascular Diseases | 8 | 2024 | 2092 | 0.600 |
Why?
|
| Upper Extremity | 1 | 2019 | 56 | 0.590 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 61 | 0.570 |
Why?
|
| Ambulatory Care | 2 | 2018 | 415 | 0.570 |
Why?
|
| Echocardiography | 6 | 2025 | 1127 | 0.540 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 132 | 0.530 |
Why?
|
| Atherosclerosis | 6 | 2024 | 1002 | 0.510 |
Why?
|
| Heart Failure | 6 | 2025 | 2428 | 0.500 |
Why?
|
| Anticholesteremic Agents | 3 | 2022 | 247 | 0.470 |
Why?
|
| Dyslipidemias | 3 | 2024 | 246 | 0.470 |
Why?
|
| Teleradiology | 1 | 2014 | 6 | 0.450 |
Why?
|
| Angiotensin Receptor Antagonists | 3 | 2024 | 138 | 0.450 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2022 | 760 | 0.450 |
Why?
|
| Computer-Assisted Instruction | 1 | 2014 | 54 | 0.440 |
Why?
|
| Bisoprolol | 2 | 2024 | 12 | 0.440 |
Why?
|
| User-Computer Interface | 1 | 2014 | 167 | 0.410 |
Why?
|
| Radiology | 1 | 2014 | 127 | 0.400 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 466 | 0.370 |
Why?
|
| Vena Cava, Superior | 1 | 2012 | 59 | 0.370 |
Why?
|
| Educational Measurement | 1 | 2014 | 332 | 0.370 |
Why?
|
| Consensus | 6 | 2024 | 725 | 0.360 |
Why?
|
| Cholesterol, LDL | 6 | 2024 | 609 | 0.360 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 310 | 0.350 |
Why?
|
| Exercise Test | 1 | 2012 | 262 | 0.350 |
Why?
|
| Stroke Volume | 4 | 2025 | 527 | 0.320 |
Why?
|
| Humans | 44 | 2025 | 133331 | 0.310 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 81 | 0.300 |
Why?
|
| Septal Occluder Device | 2 | 2023 | 45 | 0.300 |
Why?
|
| Treatment Outcome | 9 | 2024 | 13103 | 0.280 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2023 | 127 | 0.280 |
Why?
|
| Neprilysin | 2 | 2024 | 21 | 0.280 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 2 | 2024 | 15 | 0.270 |
Why?
|
| Clinical Competence | 1 | 2014 | 1069 | 0.270 |
Why?
|
| Ventricular Function, Left | 3 | 2025 | 548 | 0.260 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 1008 | 0.250 |
Why?
|
| Hypertension, Pulmonary | 2 | 2022 | 474 | 0.250 |
Why?
|
| Heart Ventricles | 2 | 2025 | 789 | 0.240 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2014 | 134 | 0.240 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 376 | 0.240 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2009 | 288 | 0.240 |
Why?
|
| Heart Murmurs | 1 | 2005 | 14 | 0.240 |
Why?
|
| Splenic Vein | 1 | 2024 | 11 | 0.220 |
Why?
|
| Hepatic Veins | 1 | 2024 | 21 | 0.220 |
Why?
|
| Male | 16 | 2025 | 65576 | 0.220 |
Why?
|
| Vascular Closure Devices | 1 | 2024 | 16 | 0.220 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 783 | 0.220 |
Why?
|
| Dihydropyridines | 1 | 2024 | 9 | 0.220 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17568 | 0.210 |
Why?
|
| Female | 15 | 2025 | 71482 | 0.210 |
Why?
|
| Calcium Channel Blockers | 1 | 2024 | 116 | 0.210 |
Why?
|
| Angiography | 1 | 2024 | 215 | 0.210 |
Why?
|
| Child | 10 | 2024 | 25863 | 0.200 |
Why?
|
| Length of Stay | 2 | 2019 | 1393 | 0.200 |
Why?
|
| Child, Preschool | 5 | 2024 | 14872 | 0.190 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2023 | 170 | 0.190 |
Why?
|
| Infant | 5 | 2024 | 13241 | 0.180 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2022 | 111 | 0.180 |
Why?
|
| Preoperative Care | 1 | 2023 | 373 | 0.170 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 199 | 0.170 |
Why?
|
| Apolipoproteins B | 1 | 2020 | 146 | 0.170 |
Why?
|
| Heart Injuries | 1 | 2020 | 46 | 0.170 |
Why?
|
| Tuberous Sclerosis | 1 | 2021 | 124 | 0.160 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 62 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2022 | 823 | 0.160 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 63 | 0.160 |
Why?
|
| Adolescent | 7 | 2024 | 20569 | 0.160 |
Why?
|
| Hypercholesterolemia | 1 | 2022 | 236 | 0.160 |
Why?
|
| Lipoprotein(a) | 1 | 2020 | 138 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2022 | 278 | 0.150 |
Why?
|
| Pulmonary Valve | 1 | 2020 | 96 | 0.150 |
Why?
|
| Adult | 8 | 2022 | 31674 | 0.150 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2020 | 184 | 0.150 |
Why?
|
| Cholesterol, HDL | 4 | 2020 | 396 | 0.150 |
Why?
|
| Balloon Valvuloplasty | 2 | 2020 | 25 | 0.150 |
Why?
|
| Acute Coronary Syndrome | 1 | 2022 | 244 | 0.150 |
Why?
|
| Fluoroscopy | 1 | 2019 | 99 | 0.150 |
Why?
|
| T-Box Domain Proteins | 1 | 2019 | 124 | 0.150 |
Why?
|
| Radiation Dosage | 1 | 2019 | 147 | 0.150 |
Why?
|
| Operative Time | 1 | 2019 | 189 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 166 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2022 | 519 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 470 | 0.140 |
Why?
|
| Proprotein Convertase 9 | 3 | 2022 | 82 | 0.140 |
Why?
|
| Pericarditis, Constrictive | 1 | 2017 | 6 | 0.140 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2017 | 21 | 0.140 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2017 | 29 | 0.130 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2017 | 22 | 0.130 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 314 | 0.130 |
Why?
|
| Risk Factors | 8 | 2024 | 10951 | 0.130 |
Why?
|
| Aorta | 1 | 2020 | 557 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2019 | 806 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2020 | 858 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 460 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 806 | 0.120 |
Why?
|
| Hypertension | 1 | 2024 | 1403 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1310 | 0.110 |
Why?
|
| Brachiocephalic Veins | 1 | 2014 | 14 | 0.110 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2014 | 40 | 0.110 |
Why?
|
| Mitral Valve Stenosis | 1 | 2014 | 38 | 0.110 |
Why?
|
| Subclavian Artery | 1 | 2014 | 72 | 0.110 |
Why?
|
| Internationality | 1 | 2014 | 137 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1079 | 0.100 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2021 | 701 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 173 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1420 | 0.100 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2021 | 793 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 3869 | 0.100 |
Why?
|
| Anaerobic Threshold | 1 | 2012 | 12 | 0.100 |
Why?
|
| Pulmonary Ventilation | 1 | 2012 | 29 | 0.090 |
Why?
|
| Cardiology | 1 | 2017 | 521 | 0.090 |
Why?
|
| Time Factors | 2 | 2020 | 6544 | 0.090 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 87 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3418 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1973 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2019 | 8630 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 593 | 0.090 |
Why?
|
| Tetralogy of Fallot | 1 | 2012 | 166 | 0.080 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 410 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2012 | 809 | 0.080 |
Why?
|
| Kinetics | 1 | 2012 | 1323 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1730 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 2762 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2014 | 542 | 0.080 |
Why?
|
| Curriculum | 1 | 2014 | 768 | 0.080 |
Why?
|
| Heart Rate | 1 | 2012 | 586 | 0.080 |
Why?
|
| Lipids | 2 | 2024 | 565 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 983 | 0.070 |
Why?
|
| Pediatrics | 1 | 2017 | 1221 | 0.070 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 133 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2009 | 540 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5443 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2022 | 2288 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2205 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1163 | 0.050 |
Why?
|
| Electrocoagulation | 1 | 2023 | 33 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2022 | 6582 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 153 | 0.050 |
Why?
|
| Tetrazoles | 1 | 2023 | 63 | 0.050 |
Why?
|
| Anthracyclines | 1 | 2022 | 44 | 0.050 |
Why?
|
| Cardiotoxicity | 1 | 2022 | 38 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2024 | 3718 | 0.050 |
Why?
|
| Dicarboxylic Acids | 1 | 2022 | 34 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2023 | 258 | 0.050 |
Why?
|
| Ezetimibe | 1 | 2022 | 98 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2023 | 284 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 126 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 238 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2005 | 999 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 367 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 475 | 0.040 |
Why?
|
| Young Adult | 3 | 2020 | 9920 | 0.040 |
Why?
|
| Pregnancy | 1 | 2012 | 7599 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2020 | 180 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2020 | 223 | 0.040 |
Why?
|
| Patients | 1 | 2020 | 127 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 338 | 0.040 |
Why?
|
| Transposition of Great Vessels | 1 | 2020 | 136 | 0.040 |
Why?
|
| Vascular Resistance | 1 | 2019 | 198 | 0.040 |
Why?
|
| Comorbidity | 1 | 2024 | 1622 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2628 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 712 | 0.040 |
Why?
|
| Triglycerides | 1 | 2020 | 616 | 0.030 |
Why?
|
| Cholesterol | 1 | 2020 | 573 | 0.030 |
Why?
|
| Life Style | 1 | 2020 | 459 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2020 | 663 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1340 | 0.030 |
Why?
|
| Incidence | 1 | 2005 | 3394 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 731 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3105 | 0.030 |
Why?
|
| Communication | 1 | 2020 | 542 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2019 | 337 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1036 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 319 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 28977 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2014 | 258 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 2161 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1597 | 0.020 |
Why?
|
| Lung | 1 | 2019 | 1571 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3415 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4577 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 6343 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 21497 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2004 | 152 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11721 | 0.010 |
Why?
|